Educational Webinars
Upcoming Webinars:
In this webinar you will learn:
Where and how AI can be integrated in the market access process
How AI-based tools can reduce time and resource demands in dossier writing
What HTA bodies and payers really accept when it comes to AI-supported evidence
Live demonstration of use cases in pricing, objection handling, and launch planning
In this webinar you will learn:
What is the biggest challenge faced by Medical Affairs?
What is driving the evolution of Medical Affairs and how does it affect us?
What are the key ambitions for Medical Affairs and what is its role in modern pharma?
How can this roadmap help to develop a positive culture of Medical Affairs Excellence?
In this webinar you will learn:
How a “perfect” payer/prescriber interview should unfold, and why most interviews never achieve this.
The evidence, through actual AI vs human case studies, that shows how AI-moderated interviews can significantly outperform human moderators.
Outperformance means more insights and deeper insights that are measurable.
The psychology of why human respondents give more depth and more honesty when talking to an AI moderator.
What this means for the future of your pharma payer and prescriber research.
Recorded Webinars:
In this webinar you will learn:
What we mean by Medical Affairs impact: Defining and understanding the concept
The 5 pillars of Medical Affairs impact: A framework for driving success
Different perspectives on impact: Short-term vs. long-term, micro vs. macro, internal vs. external
Making your impact visible: Best practices for communicating value to internal stakeholders
In this webinar you will learn how to optimally:
Allocate resources in a country across brands in an agile way
Allocate resources across tactics at brand level, ex ante and ex post
In this webinar you will learn:
Simple alternatives to traditional conjoint methods that handle complex product profiles much more effectively
Alternative approaches that require smaller sample sizes
Leveraging the vast repository of over $50 million worth of published pharma conjoint studies
Why (unfortunately) you cannot survey ChatGPT instead of doing conjoints (Harvard academics have tried!)
In this webinar you will learn:
What is better and what is more accepted: comparative RWE versus indirect comparisons based on trials.
Synthetic control groups and post-approval comparative RWE studies: How do they work?
Existing guidance and guidelines for comparative RWE studies
In this webinar you will learn:
How to personalise portfolio strategy at a country level as a component of near-term portfolio planning
How to align investment priorities when considering mid-term portfolio strategy
How to manage uncertainty in the context of portfolio planning for the long term
In this webinar you will learn:
Overview of the pharmaceutical value chain, a simple but powerful framework
How BD&L activities help leverage strengths and address weaknesses across the full value chain
Application of the value chain framework to assess strengths and weaknesses at each stage of the BD&L process
In this webinar you will learn:
Using AI and/or econometrics to analyse past payer behaviour. Because, for payers, sometimes “actions speak louder than words”.
Using meta-analysis to uncover powerful predictions from the mountain of published research papers.
Using simulators of “virtual negotiations” to understand innovative contracting schemes from your and payers’ perspectives.
In this webinar you will learn:
How to talk about value for money to clinicians and patient advocacy groups
How to align the clinical and the health economic view
How to go beyond the QALY to account for what matters to patients
How to deal with evidence gaps: the increasing role of Real World Evidence
In this webinar you will learn:
The key ways that cell and gene therapy do and do not differ from more “conventional” therapies.
The commercial significance of the fact that cell and gene therapies invariably enter the market with “one foot still in the lab” (i.e. with immature clinical data).
The vital importance of “hope-based therapy” (high levels of uncertainty) rather than “evidence-based therapy” and how customers (payers/prescribers) actually act when faced with these uncertainties.
...
In this webinar you will learn:
Understand why large language models (like ChatGPT) are fundamentally different to the predictive models used in forecasting and pricing.
Understand the “AI Cube” that tells you whether AI is likely to prove useful or not in your particular circumstances.
Learn the “three Cs” that allow successful deployment of AI: Curation. Combination. Calibration.
In this webinar you will learn:
The state of the art for measuring QALYs
The value of a QALY
Measuring health gains: beyond the QALY
In this webinar you will learn:
What is EU HTA and how will the process work?
How will the Joint Scientific Consultation process work?
How are other companies preparing for EU HTA?
What are the timelines and key considerations to successfully prepare for and navigate the EU HTA process?
In this webinar you will learn:
Which channels, media and content do my customers prefer? And where does my brand do well (and not so well) versus the competition
How do I translate my strategic imperatives, leverage points and key segments into pragmatic customer journeys?
What budget should I set aside for this? What % should go to digital?
What kind of business impact can I expect from my omnichannel plan?
In this webinar you will learn:
Understand why LCM is challenging and the key barriers to program success
Explore key needs & critical success factors at 6 crucial lifecycle decision points
Learn from successes and failures in ‘total’ lifecycle management
In this webinar you will learn:
How to extract insights from Patient Flows & Patient Journeys
How to combine patient insights with multi-stakeholder insights to identify growth opportunities in an evolving healthcare landscape
How to formulate CSFs / Strategic Imperatives for a product
In this webinar you will learn:
How to identify and map your KOLs strategically
How to set your KOL goals in line with your Medical Plan
How to ensure your KOL plan is supporting short- AND long-term success
In this webinar you will learn:
Challenge your quantitative intuitions
Avoid three common thinking traps
Develop first-aid debiasing strategies